NDAIRRIGATIONSOLUTION
Approved
Jun 1959
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
BETAPRONE (propiolactone) by Forest Devices is antibodies. Approved for rabies in all age groups. First approved in 1959.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
BETAPRONE (propiolactone) is an irrigation solution approved in 1959 for rabies treatment across all age groups. The drug functions through an antibody-based mechanism of action delivered via topical irrigation. It represents a legacy therapeutic approach to post-exposure rabies management.
LOE Approaching
As a legacy product approaching loss of exclusivity with minimal current commercial infrastructure, career growth on this brand is limited and team sizes are likely small.
Mechanism of Action
antibodies.
Indications (1)
Career Relevance
BETAPRONE represents a minimal-growth career opportunity with zero linked open positions. This is a legacy product maintained by Forest Devices with limited commercial expansion potential and declining clinical relevance in modern rabies management.
Medical Science Liaison (legacy support)
Worked on BETAPRONE at Forest Devices? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.